» Articles » PMID: 38003210

Amniotic Fluid and Placental Membranes As Sources of Stem Cells: Progress and Challenges 2.0

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Nov 25
PMID 38003210
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the second edition of this Special Issue was to collect both review and original research articles that investigate and elucidate the possible therapeutic role of perinatal stem cells in pathological conditions, such as cardiovascular and metabolic diseases, as well as inflammatory, autoimmune, musculoskeletal, and degenerative diseases [...].

References
1.
Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G . Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS One. 2013; 8(8):e71412. PMC: 3734067. DOI: 10.1371/journal.pone.0071412. View

2.
Ochiai D, Abe Y, Fukutake M, Sato Y, Ikenoue S, Kasuga Y . Cell sheets using human amniotic fluid stem cells reduce tissue fibrosis in murine full-thickness skin wounds. Tissue Cell. 2020; 68:101472. DOI: 10.1016/j.tice.2020.101472. View

3.
Tongu E, Segabinazzi L, Alvarenga M, Monteiro A, Papa F, Alvarenga M . Allogenic mesenchymal stem cell-conditioned medium does not affect sperm parameters and mitigates early endometrial inflammatory responses in mares. Theriogenology. 2021; 169:1-8. DOI: 10.1016/j.theriogenology.2021.03.019. View

4.
Wassmer C, Berishvili E . Immunomodulatory Properties of Amniotic Membrane Derivatives and Their Potential in Regenerative Medicine. Curr Diab Rep. 2020; 20(8):31. PMC: 7283202. DOI: 10.1007/s11892-020-01316-w. View

5.
Yang C, Wu M, You M, Chen Y, Luo M, Chen Q . The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases. Stem Cell Res Ther. 2021; 12(1):103. PMC: 7859900. DOI: 10.1186/s13287-021-02158-3. View